ダブルインタラクション・フュージョンによる薬物標的相互作用の予測
Xingyang Li1, Zepeng Li1, Bo Wei1
1School of Computer Science and Technology, Zhejiang Sci-Tech University, Hangzhou 310018, China.
Molecules (Basel, Switzerland)
|February 13, 2026
まとめ
Gated-Attention Dual-Fusion Drug-Target Interaction (GADFDTI) は,薬物と標的の相互作用を正確に予測することで,薬物発見を向上させます. このコンピューティングモデルは既存の方法を上回り,効率的な薬剤先導発見の有望性を示しています.
科学分野:
- 計算化学はコンピュータ化学である.
- ドラッグ・ディスカバリー・ドラッグ・ディスカバリー
- バイオインフォマティックス
背景:
- 薬剤標的相互作用 (DTI) の正確な予測は,薬剤発見に不可欠です.
- 実験的なアッセイはコストが高く,現在のコンピューティングモデルは,マルチスケール機能とクロスモダルの情報融合で苦労しています.
- 細粒子の薬物-タンパク質相互作用モデリングは依然として課題です.
研究 の 目的:
- Gated-Attention Dual-Fusion Drug-Target Interaction (GADFDTI) を提案し,DTIの予測のための新しいコンピューティングモデルを開発する.
- 既存のDTIモデルの複数のスケールの特徴を捕捉し,クロスモダルの情報を融合させるという制限に対処するためです.
- 薬剤のリード発見のための効率的なin silico prescreeningツールを開発する.
主な方法:
- 核融合モジュールを開発し,原子残基類似性フィールドを構築し,2D近隣オペレーターとゲーテッド双方向集積によって精製しました.
- 薬物グラフのためのマルチスケール密度の高いGCNと,1D-CNNブランチを持つマスクされたマルチスケール自己注意タンパク質エンコーダーを統合しました.
- ヒトと*C. elegans*の基準でGADFDTIを評価した.
主要な成果:
- GADFDTIはヒトで0.986,C. elegansで0.996という高いAUC値を達成し,最近のDTIモデルを上回った.
- このモデルは,精度とリコールに大幅な改善を示した.
- SARS-CoV-2症例研究では,GADFDTIが臨床的に支持された抗ウイルス剤を優先する能力を示しました.
結論:
- GADFDTIは,マルチスケール機能とクロスモダルの情報を統合することによって,細粒子の薬物-タンパク質相互作用を効果的にモデル化しています.
- 提案されたモデルは,既存のDTI予測方法と比較して優れたパフォーマンスを提供します.
- GADFDTIは,薬物リードを特定するための効率的なin silicoプレスクリーニングツールとして潜在性を示しています.
関連する概念動画
Pharmacokinetics: Drug–Drug Interactions
469
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
469
Drug-Receptor Interactions
7.6K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.6K
Drug toxicity: Drug–Drug Interaction
2
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
2
Drug-Receptor Interaction: Agonist
4.2K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
4.2K
Drug-Receptor Interaction: Antagonist
5.1K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
5.1K
Factors Affecting Protein-Drug Binding: Drug Interactions
617
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
617


